HPV-070 EMA report

Authors
Category Primary study
UnpublishedInformation reported in a systematic review
Year 2013
POPULATION: 9-14 yr; controls: 15-25 yr. INTERVENTION: Bivalent vaccine. COMPARISON: Alternate schedule: 2 Dose 20 ug (0,6 mo). OUTCOMES: Immunogenicity, measured at 7 months. Immunogenicity evaluation with VLP-based ELISA ATP
Epistemonikos ID: 7463365a38845f876d24169f9e9e3855b8c1e88e
First added on: Jan 10, 2016